论文部分内容阅读
肺癌位居各类肿瘤的首位,成为危害人类健康和生命的头号杀手。大部分肺癌一经临床确诊已处于中晚期,合并恶性胸腔积液和其他部位转移,治疗效果较差,预后不良。本文旨在探讨血管内皮素生长因子(vascular endothelial growth factor,VEGF)及内皮抑素(endostatin,ES)在血清中及癌性胸水中的表达水平,与非小细胞肺癌(non-small cell lung cancer,NSCLC)分期、转移和治疗的关系,了解相关的规律,为肿瘤诊断治疗提供可靠的依据。
Lung cancer ranks first in all kinds of tumors, becoming the number one killer that endangers human health and life. Most of the lung cancer has been diagnosed in the advanced stage, with malignant pleural effusion and other parts of the transfer, the treatment effect is poor, the prognosis is poor. This article aims to investigate the expression levels of vascular endothelial growth factor (VEGF) and endostatin (ES) in serum and cancerous pleural effusions in patients with non-small cell lung cancer , NSCLC) staging, metastasis and treatment of the relationship between understanding of the relevant laws for the diagnosis and treatment of cancer to provide a reliable basis.